ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00861367
Recruitment Status : Withdrawn (difficult enrollment, focus of study no longer of interest)
First Posted : March 13, 2009
Last Update Posted : November 21, 2016
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland

Brief Summary:
Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.

Condition or disease Intervention/treatment Phase
Blood Loss, Surgical Intraoperative Complications Re-operation Rates in Patients With Aspirin Treatment Drug: transurethral surgery with or without aspirin Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Care Provider, Investigator)
Primary Purpose: Prevention
Official Title: Prospektive Doppel-Blind-randomisierte Studie Zur Verwendung Von Aspirin Bei Transurethralen Operationen
Study Start Date : September 2008
Actual Primary Completion Date : January 2009
Actual Study Completion Date : January 2009

Resource links provided by the National Library of Medicine

Drug Information available for: Aspirin
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: 1
aspirin 100mg
Drug: transurethral surgery with or without aspirin
aspirin 100mg once a day, transurethral surgery with or without aspirin
Other Name: Asprin cardio 100mg
Placebo Comparator: 2
empty capsule
Drug: transurethral surgery with or without aspirin
aspirin 100mg once a day, transurethral surgery with or without aspirin
Other Name: Asprin cardio 100mg



Primary Outcome Measures :
  1. Blood loss [ Time Frame: intraoperative, 6 hours post op, 3 days postop ]

Secondary Outcome Measures :
  1. Reoperation rates [ Time Frame: during hospitalization ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Transurethral surgery of the bladder or prostate, informed consent, age over 18

Exclusion Criteria:

  • Oral anticoagulation,

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00861367


Locations
Switzerland
Urologische Universitätsklinik Basel-Liestal
Liestal, Switzerland, 4410
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Study Chair: Thomas C Gasser, Prof Department of Urology, Liestal

Responsible Party: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT00861367     History of Changes
Other Study ID Numbers: 05/08
First Posted: March 13, 2009    Key Record Dates
Last Update Posted: November 21, 2016
Last Verified: November 2016

Keywords provided by University Hospital, Basel, Switzerland:
aspirin
blood loss
transurethral surgery

Additional relevant MeSH terms:
Hemorrhage
Blood Loss, Surgical
Intraoperative Complications
Pathologic Processes
Aspirin
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Platelet Aggregation Inhibitors
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Antipyretics